Ohio Department of Health
STD PCHD: Strengthening STD Prevention and Control for Health Departments
The Ohio Department of Health (ODH) is submitting an application for the Notice of Funding Opportunity (NOFO): CDC-RFA-PS19-1901: Strengthening STD Prevention and Control for Health Departments (STD PCHD).
Over the past five years, 2013 to 2017, the number of reported chlamydia (CT) cases has increased by 15.2%, the number of reported gonorrhea (GC) cases has increased by 44.0%, while the number of primary and secondary (P&S) syphilis cases has increased be 89.3%. The number of congenital syphilis cases has fluctuated from 13 to 19 cases during this period. In 2017, there were over 84,000 cases of CT and GC reported in Ohio, which resulted in case rates of 528.9 per 100,000 for CT and 206.6 per 100,000 for GC. A total of 1,899 cases of syphilis (all stages) were reported, of which 833 were cases of P&S syphilis for a rate of 7.2 per 100,000). In 2017, there were 17 reported congenital syphilis (CS) cases for a rate of 12.3 per 100,000.
STDs continue to disproportionately affect adolescents, young adults, and men who have sex with men (MSM), including racial and ethnic minorities among these populations. In Ohio, the most at-risk population for GC and CT continues to be African American females between the ages of 15-24. African Americans had a GC rate 12 times higher and a CT rate seven times higher than Whites in 2017. Adolescents and young adults between the ages of 15-24 accounted for 63% of all GC and CT cases in 2017. In Ohio’s three largest high-morbidity areas (HMAs), Cuyahoga, Franklin, and Hamilton Counties, 74.2% of the male P&S cases are MSM and 43.7% are also HIV positive. Having anonymous sex partners is an increasing issue in Ohio. In 2017, 53.3% of P&S syphilis cases reported having sex with an anonymous partner.
The purpose of the STD PCHD NOFO is to prevent and control three major STDs: chlamydia, gonorrhea, and syphilis. The NOFO supports strategies and activities to: eliminate congenital syphilis; prevent antibiotic resistant gonorrhea; reduce primary and secondary syphilis; prevent STD-related pelvic inflammatory disease, ectopic pregnancy, and infertility; address STD-related outbreaks; and reduce STD-related health disparities. Ohio aims to strengthen STD prevention activities to achieve stated outcomes by utilizing the strategies outlined in the application.
Utilizing the strategies described throughout the application, Ohio will promote more targeted screenings and treatment per CDC recommendations, and improve services for STD clients and their partners by reinforcing partner services, providing expedited partner therapy, monitoring linkage to care, and reducing re-infection. Ohio will also focus efforts on increasing community and provider knowledge of STD-related treatment, prevention, epidemiology and establishing effective policies. By the end of the project period, Ohio will achieve the long-term outcomes of reduced incidence of STDs, improve integration of STD and HIV prevention into clinical care, increase access to care, and reduce threats of emerging antibiotic resistant GC and congenital syphilis.